Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
about
Assessing bleeding risk in patients taking anticoagulantsSubclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devicesEfficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysisThe management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey.Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.Stroke and bleeding risk in atrial fibrillation.Study protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcareA cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesUse of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?Supporting Treatment decision making to Optimise the Prevention of STROKE in Atrial Fibrillation: the STOP STROKE in AF study. Protocol for a cluster randomised controlled trial.Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.The decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years?Assessment of endothelial (dys)function in atrial fibrillation.Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures.Top practice-changing articles over the last two years.2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.Juvenile StrokeAnticoagulant Therapy-Induced Gallbladder Hemorrhage after Cardiac Valve Replacement.Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome.Prevalence of atrial fibrillation in intracerebral hemorrhage.Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke.A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry.Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients.Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry.Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients.Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach.Anticoagulation Resumption After Intracerebral Hemorrhage.Bleeding risk with oral anticoagulation - new frontiers and new questions
P2860
Q24619070-8FFF69A5-0413-4442-9246-C3E517B7EED5Q28074643-81AF34F1-623B-466A-A837-1522D53E09ABQ28081598-2BCACBB4-E9BE-4188-926B-794F4F188963Q33384911-CDE6C758-28B3-4145-B815-4AD773A13815Q33793622-A70CDC92-C317-4E5D-BA93-CFFC9002A64AQ34269633-DC86BEAC-29B7-48F8-88F1-C5C88361664FQ35063716-FFE28DEF-6614-4C63-8D38-8A6FAB1FFB18Q35089113-F80D5043-70FA-4B17-A093-EC4288A0705FQ35752619-D8A60930-AC7A-4D71-9F4B-296BF01DDAE0Q35968875-9D5BA366-F324-4CCA-BFE9-62C3F8E0234AQ36021753-E3DBC46F-7ABB-43AE-AF04-9E810EA2318DQ36235962-1F199B12-E85A-41D0-AF7C-2372CA2FEF0EQ36409072-9FFB6E0D-1819-4A99-94BF-197368855319Q37098181-C77D8BB7-BFFA-4EDF-AA11-F9730A5CCACBQ37587835-B6DF1569-019A-4DF3-8859-F74D0FB5B45FQ37990454-7B7C4E72-8EA5-4A70-A1DA-8F0D3A19B370Q38068113-E4B9971A-3457-4A53-84D2-DBF6A4525013Q38086147-D24928F8-8F7B-4B40-ABF1-59431C24CB5AQ38563391-3DF11361-8421-4FF3-9E24-7F7CE1E10D31Q40503229-803A4FEA-1077-4E98-8EA7-E23750D79AADQ41182747-43044913-B5C3-4ABA-AF49-1EAB05129D1BQ42043771-45164E1D-532A-480E-AE60-856D02F7B73DQ42146631-A78BFFAC-2E83-406D-B729-E292486C934EQ43650765-FB5109D6-367C-4D34-A571-3632238785FBQ43731593-B4F01452-03AA-4A4F-9458-F14A4CC3A9FFQ44739550-0C5A78F3-6418-4048-AC40-97C6CC409FDEQ47094449-9FC31533-DAE7-4B4E-BECF-9CBDDF385623Q47114806-50EF7F5F-662D-484B-AC20-4A30264BBC4AQ47823178-C4F7F820-935A-4380-B5D7-47C4287C399BQ48021946-9682EF2E-2F73-48C1-9633-27AA70D177DDQ50098252-B94FF470-27EB-4B0C-9AC9-DC22379FF2EAQ50794115-D8C79507-E912-4A70-B4DE-13C3995EF4A1Q51025724-721E0ECA-7D37-4B64-995A-288A6282882EQ55047549-52CF7318-70A1-4788-9BD7-B89BEC47398CQ57252900-2DE2E501-B8C5-44F4-9E84-EE1494BA4479
P2860
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@ast
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@en
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@nl
type
label
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@ast
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@en
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@nl
prefLabel
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@ast
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@en
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@nl
P2093
P921
P3181
P1476
Adjusted-dose warfarin versus ...... ients with atrial fibrillation
@en
P2093
Lesly A Pearce
Maria I Aguilar
Robert G Hart
P3181
P356
10.7326/0003-4819-147-8-200710160-00018
P407
P577
2007-10-16T00:00:00Z